Department of Pharmacology, Institute of Biomedical Sciences, University of São Paulo, São Paulo, Brazil.
Am J Physiol Heart Circ Physiol. 2010 Jul;299(1):H25-35. doi: 10.1152/ajpheart.00620.2009. Epub 2010 Apr 9.
We recently observed the enhanced serine and matrix metalloproteinase (MMP) activity in the spontaneously hypertensive rat (SHR) compared with its normotensive Wistar-Kyoto (WKY) rat and the cleavage of membrane receptors in the SHR by MMPs. We demonstrate in vivo that MMP-7 and MMP-9 injection leads to a vasoconstrictor response in microvessels of rats that is blocked by a specific MMP inhibitor (GM-6001, 1 microM). Multiple pathways may be responsible. Since the beta(2)-adrenergic receptor (beta(2)-AR) is susceptible to the action of endogenous MMPs, we hypothesize that MMPs in the plasma of SHRs are able to cleave the extracellular domain of the beta(2)-AR. SHR arterioles respond in an attenuated fashion to beta(2)-AR agonists and antagonists. Aorta and heart muscle of control Wistar rats were exposed for 24 h (37 degrees C) to fresh plasma of male Wistar and WKY rats and SHRs with and without doxycycline (30 microM) and EDTA (10 mM) to reduce MMP activity. The density of extracellular and intracellular domains of beta(2)-AR was determined by immunohistochemistry. The density of the extracellular domain of beta(2)-AR is reduced in aortic endothelial cells and cardiac microvessels of SHRs compared with that of WKY or Wistar rats. Treatment of the aorta and the heart of control Wistar rats with plasma from SHRs, but not from WKY rats, reduced the number of extracellular domains, but not intracellular domains, of beta(2)-AR in aortic endothelial cells and cardiac microvessels. MMP inhibitors (EDTA and doxycycline) prevented the cleavage of the extracellular domain. Thus MMPs may contribute to the reduced density of the extracellular domain of beta(2)-AR in blood vessels and to the increased arteriolar tone of SHRs compared with normotensive rats.
我们最近观察到自发性高血压大鼠(SHR)中丝氨酸和基质金属蛋白酶(MMP)活性增强,与正常血压的 Wistar-Kyoto(WKY)大鼠相比,以及 MMP 对 SHR 中膜受体的裂解。我们在体内证明,MMP-7 和 MMP-9 的注射会导致大鼠微血管的血管收缩反应,这种反应被特定的 MMP 抑制剂(GM-6001,1μM)阻断。可能有多种途径负责。由于β2-肾上腺素能受体(β2-AR)易受内源性 MMP 的作用,我们假设 SHR 血浆中的 MMP 能够裂解β2-AR 的细胞外结构域。SHR 小动脉对β2-AR 激动剂和拮抗剂的反应减弱。控制 Wistar 大鼠的主动脉和心肌在 37°C 下暴露于新鲜雄性 Wistar 和 WKY 大鼠以及 SHR 的血浆中 24 小时,并用强力霉素(30μM)和 EDTA(10mM)处理以减少 MMP 活性。通过免疫组织化学测定β2-AR 的细胞外和细胞内结构域的密度。与 WKY 或 Wistar 大鼠相比,SHR 的主动脉内皮细胞和心脏微血管中的β2-AR 细胞外结构域的密度降低。用 SHR 的血浆而不是 WKY 大鼠的血浆处理控制的 Wistar 大鼠的主动脉和心脏,减少了主动脉内皮细胞和心脏微血管中β2-AR 的细胞外结构域的数量,但不减少细胞内结构域的数量。MMP 抑制剂(EDTA 和强力霉素)可防止细胞外结构域的裂解。因此,MMP 可能有助于降低血管中β2-AR 细胞外结构域的密度,并增加与正常血压大鼠相比 SHR 的小动脉张力。